NCT05318495

Brief Summary

Single-center, four-arm dual-tandem, randomized, open-label study involving the following devices:

  1. 1.The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).
  2. 2.CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas.
  3. 3.The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
372

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 29, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 8, 2022

Status Verified

April 1, 2022

Enrollment Period

9 months

First QC Date

March 29, 2022

Last Update Submit

April 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Additional adenoma detection yield

    additional adenoma detection yield (represented by the miss rate) of CAD-EYE and G-EYE® colonoscopy over standard coloscopy compared to the additional adenoma detection yield of CAD-EYE aided colonoscopy over standard colonoscopy

    6 weeks

Study Arms (4)

Standard Colonoscopy+CAD-EYE followed by Standard Colonoscopy

EXPERIMENTAL

CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas. The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).

Device: Standard ColonoscopyDevice: CAD-EYE

Standard Colonoscopy followed by Standard Colonoscopy+CAD-EYE

ACTIVE COMPARATOR

CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas. The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).

Device: Standard ColonoscopyDevice: CAD-EYE

Standard Colonoscopy+CAD-EYE+G-EYE followed by Standard Colonoscopy

EXPERIMENTAL

CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas. The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI). The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.

Device: Standard ColonoscopyDevice: CAD-EYEDevice: G-EYE

Standard Colonoscopy followed by Standard Colonoscopy+CAD-EYE+G-EYE

ACTIVE COMPARATOR

CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas. The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI). The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.

Device: Standard ColonoscopyDevice: CAD-EYEDevice: G-EYE

Interventions

The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).

Standard Colonoscopy followed by Standard Colonoscopy+CAD-EYEStandard Colonoscopy followed by Standard Colonoscopy+CAD-EYE+G-EYEStandard Colonoscopy+CAD-EYE followed by Standard ColonoscopyStandard Colonoscopy+CAD-EYE+G-EYE followed by Standard Colonoscopy
CAD-EYEDEVICE

CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas.

Standard Colonoscopy followed by Standard Colonoscopy+CAD-EYEStandard Colonoscopy followed by Standard Colonoscopy+CAD-EYE+G-EYEStandard Colonoscopy+CAD-EYE followed by Standard ColonoscopyStandard Colonoscopy+CAD-EYE+G-EYE followed by Standard Colonoscopy
G-EYEDEVICE

The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.

Standard Colonoscopy followed by Standard Colonoscopy+CAD-EYE+G-EYEStandard Colonoscopy+CAD-EYE+G-EYE followed by Standard Colonoscopy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Screening and surveillance population for Adenoma and CRC.
  • The patient must understand and sign a written informed consent for the procedure.

You may not qualify if:

  • Subjects with inflammatory bowel disease;
  • Subjects with a personal history of hereditary polyposis syndrome;
  • Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  • Subjects with diverticulitis or toxic megacolon;
  • Subjects with a history of radiation therapy to abdomen or pelvis;
  • Pregnant or lactating female subjects;
  • Subjects who are currently enrolled in another clinical investigation.
  • Subjects with current oral or parenteral use of anticoagulants, not considered eligible by the investigator.
  • Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
  • Any patient condition deemed too risky for the study by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helios Dr. Horst Schmidt Kliniken

Wiesbaden, 65199, Germany

RECRUITING

MeSH Terms

Conditions

AdenomaColonic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Ralf Kiesslich, Prof.

    Helios Dr. Horst Schmidt Kliniken Wiesbaden

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

March 29, 2022

First Posted

April 8, 2022

Study Start

March 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

April 8, 2022

Record last verified: 2022-04

Locations